Adicet Bio Inc (ACET NASDAQ) stock market data APIs
$9.488
-0.41(-4.3%)
as of August 19, 2026
Try our APIs with
free plan!
Adicet Bio Inc Financial Data Overview
Price chart is built with
Anychart
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Prev. Close
9.488
Open
9.0751
High
9.607
Low
8.9219
52 wk Range
6.01-17.4384
Market Cap
88 841 K
Shares Outstanding
9 361 K
EPS
-1.99
Beta
1.594
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Adicet Bio Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adicet Bio Inc data using free add-ons & libraries
Get Adicet Bio Inc Fundamental Data
Adicet Bio Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -98 121 000
- Earnings Per Share: -10
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -2.43
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adicet Bio Inc News
New
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Adicet Bio, Inc. (ACET) is a stock that can certainly grab the a...
Lipocine Appoints Michael J. Grissinger to Board of Directors
SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral del...
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 28, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and deve...
Adicet Bio To Implement 1-for-16 Reverse Stock Split On December 30
(RTTNews) - Adicet Bio (ACET) said its board has approved a one-for-16 reverse stock split of the company's common stock as part of efforts to regain compliance with Nasdaq's minimum bid price require...
Get Adicet Bio Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
